Revenue (TTM) Chart

View Revenue (TTM) for CTEV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (TTM) Chart
Start Trial

Historical Revenue (TTM) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 994.67M
March 31, 2026 978.76M
December 31, 2025 965.41M
September 30, 2025 951.00M
June 30, 2025 935.54M
March 31, 2025 927.45M
December 31, 2024 930.62M
September 30, 2024 942.61M
June 30, 2024 954.92M
March 31, 2024 959.44M
December 31, 2023 961.52M
September 30, 2023 958.48M
Date Value
June 30, 2023 966.13M
March 31, 2023 1.018B
December 31, 2022 1.080B
September 30, 2022 1.137B
June 30, 2022 1.175B
March 31, 2022 1.161B
December 31, 2021 1.118B
September 30, 2021 1.075B
June 30, 2021 1.010B
March 31, 2021 940.60M
December 31, 2020 937.76M
September 30, 2020 682.42M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (TTM) Range, Past 5 Years

View Revenue (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (TTM) Benchmarks

View Revenue (TTM) Benchmarks
Start Trial
LataMed AI Corp. 0.00
SCWorx Corp. 2.926M
Health Catalyst, Inc. 292.24M
GoodRx Holdings, Inc. 785.23M
iSpecimen, Inc. 0.4663M